Differential Activation of Multiple Signalling Pathways Dictates eNOS Upregulation by FGF2 but not VEGF in Placental Artery Endothelial Cells

Placenta

Volumn 29, Issue 8, 2008, Pages 708-717

  Mata Greenwood, Eugenia ^a   Liao, Wu Xiang ^a   Zheng, Jing ^b   Chen, Dong Bao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Endothelial cells; eNOS protein; FGF2; Placenta; Signalling pathways; VEGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOBLOTTING; NONHUMAN; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHEEP; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 8; NITRIC OXIDE SYNTHASE TYPE III; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; PROTEIN KINASES; SHEEP; SIGNAL TRANSDUCTION; UMBILICAL ARTERIES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49049101857     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.05.005     Document Type: Article

References (33)

1. Reynolds L.P., and Redmer D.A. Angiogenesis in the placenta. Biol Reprod 64 (2001) 1033-1040
2. Charnock-Jones D.S., Kaufmann P., and Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis. Molecular Regulation. Placenta 25 (2004) 103-113
3. Magness R.R., and Zheng J. Maternal cardiovascular alterations during pregnancy. In: Gluckman P.D., and Hermann M.A. (Eds). Pediatric and perinatal perspectives (1996), Edward Arnold Publishers, London 762-772
4. Borowicz P.P., Arnold D.R., Johnson M.L., Grazul-Bilska A.T., Redmer D.A., and Reynolds L.P. Placental growth throughout the last two thirds of pregnancy in sheep: vascular development and angiogenic factor expression. Biol Reprod 76 (2007) 259-267
5. Choi J.W., Im M.W., and Pai S.H. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 32 (2002) 257-263
6. Sheppard C., Shaw C.E., Li Y., Bird I.M., and Magness R.R. Endothelium-derived nitric oxide synthase protein expression in ovine placental arteries. Biol Reprod 64 (2001) 1494-1499
7. Casanello P., and Sobrevia L. Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems y+/hCAT-1 and y+/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res 99 (2002) 570-577
8. Kostyk S.K., Kourembanas S., Wheeler E.L., Medeiros D., McQuillan P.A., D'Amore P.A., et al. Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol 269 (1995) H1583-H1589
9. Shen B.Q., Lee D.Y., and Zioncheck T.F. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274 (1999) 33057-33063
10. Wang Y., Nagase S., and Koyama A. Stimulatory effect of IGF-1 and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. Nitric Oxide 10 (2004) 25-35
11. Zheng J., Bird I.M., Melsaether A.M., and Magness R.R. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140 (1999) 1399-1407
12. Zheng J., Wen Y., Song Y., Wang K., Chen D.B., and Magness R.R. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation. Biol Reprod 78 (2008) 143-150
13. Chen D.B., Bird I.M., Zheng J., and Magness R.R. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of eNOS by estrogen in uterine artery endothelial cells. Endocrinol 145 (2004) 113-125
14. Zheng J., Wen Y., Chen D.B., Bird I.M., and Magness R.R. Angiotensin II elevates nitric oxide synthase 3 expression and nitric oxide production via a mitogen-activated protein kinase cascade in ovine fetoplacental artery endothelial cells. Biol Reprod 72 (2005) 1421-1428
15. Davis M.E., Cai H., Drummond G.R., and Harrison D.G. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 89 (2001) 1073-1080
16. Rubin J., Murphy T.C., Zhu L., Roy E., Nanes M.S., and Fan X. Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERK2/1 MAPK. J Biol Chem 278 (2003) 34018-34025
17. Fisslthaler B., Benzing T., Busse R., and Fleming I. Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. Nitric Oxide 8 (2003) 253-261
18. Cieslik K., Abrams C.S., and Wu K.K. Upregulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase γ/Janus Kinase 2/MEK-1-dependent pathway. J Biol Chem 276 (2001) 1211-1219
19. Dailey L., Ambrosetti D., Mansukhani A., and Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16 (2005) 233-247
20. Olsson A.K., Dimberg A., Kreuger J., and Claesson-Welsh L. VEGF receptor signaling- in control of vascular function. Nature Rev 7 (2006) 359-371
21. Zheng J., Magness R.R., and Bird J.M. A cell model for studying expression of feto-placental artery endothelial cell angiotensin II type 1 receptors and nitric oxide synthase. Med Biochem 1 (1988) 57-64
22. Qian X.X., Mata-Greenwood E., Liao W.X., Zhang H., Zheng J., and Chen D.B. Transcriptional regulation of endothelial nitric oxide synthase expression in uterine artery endothelial cells by c-Jun/AP-1. Mol Cell Endocrinol 279 (2007) 39-51
23. Santos S.D., Verveer P.J., and Bastiaens P.I. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 9 (2007) 247-249
24. Yamamoto T., Ebisuya M., Ashida F., Okamoto K., Yonehara S., and Nishida E. Continuous ERK activation downregulates anti-proliferative genes throughout G1 phase to allow cell cycle progression. Curr Biol 16 (2006) 1171-1182
25. Pintucci G., Yu P.J., Sharony R., Baumann F.G., Saponara F., Frasca A., et al. Induction of stromelysin-1 (MMP3) by fibroblast growth factor-2 (FGF2) in FGF2-/- microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK2/1). J Cell Biochem 90 (2003) 1015-1025
26. Whitney J.A., German Z., Sherman T.S., Yuhanna I.S., and Shaul P.W. Cell growth modulates nitric oxide synthase expression in fetal pulmonary artery endothelial cells. Am J Physiol 278 (2000) L131-L138
27. Veomett G., Kuszynski C., Kazakoff P., and Rizzino A. Cell density regulates the number of cell surface receptors for fibroblast growth factor. Biochem Biophys Res Commun 159 (1989) 694-700
28. Li H., Wallerath T., and Forstermann U. Physiological mechanisms regulating the expression of endothelial NO-synthase. Nitric Oxide 7 (2002) 132-147
29. Xing F., Jiang Y., Liu J., Zhao K., Mo Y., Liu Z., et al. Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation. Biochem Cell Biol 84 (2006) 780-788
30. Wu L.W., Mayo L.D., Dunbar J.D., Kessler K.M., Baerwald M.R., Jaffe E.A., et al. Utilization of distinct signaling pathways by receptors for vascular endothelial growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275 (2000) 5096-5103
31. Mansouri A., Ridgway L.D., Korapati A.L., Zhang Q., Tian L., Wang Y., et al. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278 (2003) 19245-19256
32. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., et al. p38 and ERK in platelet-derived growth factor-induced vascular proliferation, migration and gene expression. Arterioscler Thromb Vasc Biol 23 (2003) 795-801
33. Papoutsopoulou S., Symons A., Tharmalingham T., Belich M.P., Kaiser F., Kioussis D., et al. IBIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nat Immunol 7 (2006) 606-615